Travellers with Special Needs

  • Joseph Torresi
  • Sarah McGuinness
  • Karin Leder
  • Daniel O’Brien
  • Tilman Ruff
  • Mike Starr
  • Katherine Gibney


Certain groups may be at increased risk or may face particular issues when travelling. Pregnant travellers and children present several questions around vaccination, travellers’ diarrhoea, malaria and noninfectious problems that are distinctly different to other travellers. These issues are dealt with in Sects. 7.1 and 7.2. Older travellers (Sect. 7.3) are also becoming increasingly recognised as having several specific requirements that deserve their own consideration. Other groups of travellers including humanitarian workers, expatriates, VFRs and those with underlying chronic medical conditions (Sects. 7.4–7.9) all have varied requirements that are different to the standard adult traveller. Immunocompromised hosts (Sects. 7.10–7.12) present a further challenge for the travel medicine practitioner and require a significant level of expertise in order to deal with the many difficult issues that will arise within a consultation. Finally, medical tourists (Sect. 7.13) pose an entirely different set of issues that practitioners must become familiar with. This chapter provides specific information and recommendations regarding these varied groups of travellers.

Key Reading

The Pregnant Traveller

  1. ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 443: air travel during pregnancy. Obstet Gynecol. 2009;114:954–5.CrossRefGoogle Scholar
  2. Antony K, Ehrenthal D, Evensen A, Iruretagoyena J. Travel during pregnancy: considerations for the obstetric provider. Obstet Gynecol Surv. 2017;72:97–115.PubMedCrossRefGoogle Scholar
  3. Carroll I, Williams D. Pre-travel vaccination and medical prophylaxis in the pregnant traveler. Travel Med Infect Dis. 2008;6:259–75.PubMedCrossRefGoogle Scholar
  4. Igbinosa I, Rabe I, Oduyebo T, Rasmussen S. Zika virus: common questions and answers. Am Fam Physician. 2017;95:507–13.PubMedGoogle Scholar
  5. McGready R, Hamilton KA, Simpson JA, Cho T, Luxemburger C, Edwards R, Looareesuwan S, White NJ, Nosten F, Lindsay S. Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy. Am J Trop Med Hyg. 2001;65:285–9.PubMedCrossRefGoogle Scholar
  6. Roggelin L, Cramer J. Malaria prevention in the pregnant traveller: a review. Travel Med Infect Dis. 2014;12:229–36.PubMedCrossRefGoogle Scholar
  7. Women’s Health Committee, The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. College Statement: Influenza vaccination during pregnancy (and in women planning pregnancy). 2018. Accessed 24 Aug 2018.


  1. Australian Immunisation Handbook, Australian Government Department of Health, Canberra. 2018.
  2. Fischer P, Bialek R. Prevention of malaria in children. Clin Infect Dis. 2002;34(4):493–8.PubMedCrossRefGoogle Scholar
  3. Lau C, Streeton C, David M, Sly P, Mills D. The tolerability of a combined hepatitis A and typhoid vaccine in children aged 2-16 years: an observational study. J Travel Med. 2016;23:tav023.PubMedCrossRefGoogle Scholar
  4. Starr M. Paediatric travel medicine: vaccines and medications. Br J Clin Pharmacol. 2013;75(6):1422–32.PubMedCrossRefGoogle Scholar
  5. Veltri JC, Osimitz TG, Bradford DC, Page BC. Retrospective analysis of calls to poison control centers resulting from exposureto the insect repellent N,N-diethyl-M-toluamide (DEET) from 1985–1989. J Toxicol Clin Toxicol. 1994;32(1):1–16.PubMedCrossRefGoogle Scholar
  6. Yaron M, Niermeyer S. Travel to high altitude with young children: an approach for clinicians. High Alt Med Biol. 2008;9(4):265–9.PubMedCrossRefGoogle Scholar

Older Travellers

  1. Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372(12):1114–25.PubMedCrossRefGoogle Scholar
  2. Boraschi D, Italiani P. Immunosenescence and vaccine failure in the elderly: strategies for improving response. Immunol Lett. 2014;162(1 Pt B):346–53.PubMedCrossRefGoogle Scholar
  3. Burke M, Rowe T. Vaccinations in older adults. Clin Geriatr Med. 2018;34(1):131–43.PubMedCrossRefGoogle Scholar
  4. Cramer JP, Dubischar K, Eder S, Burchard GD, Jelinek T, Jilma B, et al. Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO(R) in elderly subjects: open-label, uncontrolled, multi-center, phase 4 study. Vaccine. 2016;34(38):4579–85.PubMedCrossRefGoogle Scholar
  5. Del Giudice G, Goronzy JJ, Grubeck-Loebenstein B, Lambert PH, Mrkvan T, Stoddard JJ, et al. Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging. NPJ Aging Mech Dis. 2018;4:1.PubMedCrossRefGoogle Scholar
  6. DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371(7):635–45.PubMedCrossRefGoogle Scholar
  7. Doherty TM, Connolly MP, Del Giudice G, Flamaing J, Goronzy JJ, Grubeck-Loebenstein B, et al. Vaccination programs for older adults in an era of demographic change. Eur Geriatr Med. 2018;9(3):289–300.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Erra EO, Kantele A. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis. Expert Rev Vaccines. 2015;14(9):1167–79.PubMedCrossRefGoogle Scholar
  9. Ewald H, Briel M, Vuichard D, Kreutle V, Zhydkov A, Gloy V. The clinical effectiveness of pneumococcal conjugate vaccines: a systematic review and meta-analysis of randomized controlled trials. Dtsch Arztebl Int. 2016;113(9):139–46.PubMedPubMedCentralGoogle Scholar
  10. Gautret P, Gaudart J, Leder K, Schwartz E, Castelli F, Lim PL, et al. Travel-associated illness in older adults (>60 y). J Travel Med. 2012;19(3):169–77.PubMedCrossRefGoogle Scholar
  11. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14(5):428–36.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Haq K, McElhaney JE. Ageing and respiratory infections: the airway of ageing. Immunol Lett. 2014;162(1 Pt B):323–8.PubMedCrossRefGoogle Scholar
  13. Lindsey NP, Rabe IB, Miller ER, Fischer M, Staples JE. Adverse event reports following yellow fever vaccination, 2007-13. J Travel Med. 2016;23(5).CrossRefGoogle Scholar
  14. Linton PJ, Thoman ML. Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart. Immunol Lett. 2014;162(1 Pt B):290–7.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Swanson KA, Schmitt HJ, Jansen KU, Anderson AS. Adult vaccination. Hum Vaccin Immunother. 2015;11(1):150–5.PubMedCrossRefGoogle Scholar
  16. Theeten H, Van Herck K, Van Der Meeren O, Crasta P, Van Damme P, Hens N. Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions. Vaccine. 2015;33(42):5723–7.PubMedCrossRefGoogle Scholar
  17. The Older Traveller: a guide for the health professional. 1st ed. In: Baker L, Brink GK, Lipschitz S, Marcolongo T, editors. South African Society of Travel Medicine (SASTM), South African Society of Geriatrics and the International Association for Medical Assistance to Travellers (IAMAT). Dunvegan: SASTM Publications; 2016.Google Scholar
  18. Van Der Meeren O, Crasta P, de Ridder M. A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix in healthy adults. Hum Vaccin Immunother. 2015;11(7):1729–34.CrossRefGoogle Scholar
  19. Weinberger B. Vaccines for the elderly: current use and future challenges. Immun Ageing. 2018;15:3.PubMedPubMedCentralCrossRefGoogle Scholar

Expatriates and Long-Term Travellers

  1. Gamble KL, Lovell-Hawker DM. Expatriates. In: JS Keystone, P Kozarsky, D O’Freedman, HD Northdurft, BA Connor, editors. Travel medicine. Mosby Elsevier; 2008.Google Scholar
  2. O’Brien DP, Biggs BA. Malaria in the expatriate and long-term traveller. Aust Prescr. 2002;25(3):66–9.CrossRefGoogle Scholar
  3. Shepherd SM, Shoff WH. Vaccination for the expatriate and long-term traveler. Expert Rev Vaccines. 2014;13(6):775–800.PubMedCrossRefGoogle Scholar
  4. Toovey S, Moerman F, Van Gompel A. Special infectious diseases risks of expatriates and long-term travelers in tropical countries. Part II: infections other than malaria. J Travel Med. 2007;14(1):50–60.PubMedCrossRefGoogle Scholar

Humanitarian and Health Workers

  1. Aid Worker Security Database. Aid worker security report 2018: figures at a glance. 2018.
  2. Brooks SK, Dunn R, Sage CA, Amlot R, Greenberg N, Rubin GJ. Risk and resilience factors affecting the psychological well-being of individuals deployed in humanitarian relief roles after a disaster. J Ment Health. 2015;24(6):385–413.PubMedCrossRefGoogle Scholar
  3. Gushalak BD. Humanitarian aid workers. Updated 31 May 2017. In: Centers for Disease Control and Prevention, editor. CDC Yellow Book 2018. Health information for international travel. Atlanta: CDC; 2018.
  4. Wu HM, Dhara R, Czarkowski AG, Nilles EJ. Health care workers. Updated 31 May 2017. In: Centers for Disease Control and Prevention, editor. CDC Yellow Book 2018. Health information for international travel. Atlanta: CDC; 2018.
  5. Chen LH, Hamer DH. Long-term travellers and expatriates. Updated 31 May 2017. In: Centers for Disease Control and Prevention, editor. CDC Yellow Book 2018. Health information for international travel. Atlanta: CDC; 2018.
  6. NHMRC. Vaccination for people at occupational risk. Updated 5 June 2018. In: Australian Immunisation Handbook [Available Online].

Travellers Visiting Friends and Relatives

  1. Angell SY, Behrens RH. Risk assessment and disease prevention in travelers visiting friends and relatives. Infect Dis Clin North Am. 2005;19(1):49–65.PubMedCrossRefGoogle Scholar
  2. Angell SY, Cetron MS. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med. 2005;142(1):67–72.PubMedCrossRefGoogle Scholar
  3. Bacaner N, Stauffer B, Boulware DR, Walker PF, Keystone JS. Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA. 2004;291(23):2856–64.PubMedCrossRefGoogle Scholar
  4. Bui YG, Trepanier S, Milord F, Blackburn M, Provost S, Gagnon S. Cases of malaria, hepatitis A, and typhoid fever among VFRs, Quebec (Canada). J Travel Med. 2011;18:373–8.PubMedCrossRefGoogle Scholar
  5. Heywood AE, Zwar N, Forssman BL, Seale H, Stephens N, Musto J, et al. The contribution of travellers visiting friends and relatives to notified infectious diseases in Australia: state-based enhanced surveillance. Epidemiol Infect. 2016;144(16):3554–63.PubMedPubMedCentralCrossRefGoogle Scholar
  6. LaRocque RC, Deshpande BR, Rao SR, Brunette GW, Sotir MJ, Jentes ES, et al. Pre-travel health care of immigrants returning home to visit friends and relatives. Am J Trop Med Hyg. 2013;88:376–80.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Leder K, Tong S, Weld L, Kain KC, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006;43:1185–93.PubMedCrossRefGoogle Scholar

Travellers with Cardiovascular Problems

  1. Hammadah M, et al. Navigating air travel and cardiovascular concerns: is the sky the limit? Clin Cardiol. 2017;40(9):660–6.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Possick SE, Barry M. Air travel and cardiovascular disease. J Travel Med. 2004;11:243–50.PubMedCrossRefGoogle Scholar

Travellers with Chronic Lung Disease

  1. Mileno MD, Bia FJ. The compromised traveller. Infect Dis Clin North Am. 1998;12(2):369–412.PubMedCrossRefGoogle Scholar
  2. Nicholson TT, Sznajder JI. Fitness to fly in patients with lung disease. Ann Am Thorac Soc. 2014;11(10):1614–22.PubMedCrossRefGoogle Scholar
  3. Patterson JE. The pre-travel medical evaluation: the traveller with chronic illness and the geriatric traveller. Yale J Biol Med. 1992;65:317–27.PubMedPubMedCentralGoogle Scholar
  4. Sohail MR, Fischer PR. Health risks to air travelers. Infect Dis Clin North Am. 2005;19:67–84.PubMedCrossRefGoogle Scholar

Travellers with Diabetes

  1. Kerr D, Martinez J. (Samsun Diabetes Research Institute). Diabetes travel.
  2. Mullin R, Kruger D, Young CF, Shubrook JH. Navigating travel with diabetes. Cleve Clin J Med. 2018;85(7):537–42.PubMedCrossRefGoogle Scholar
  3. Sane T, Koivisto VA, Nikkanen P, Pelkonen R. Adjustment of insulin doses of diabetic patients during long distance flights. BMJ. 1990;301(6749):421–2.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Zwar N. Travelling with medicines in 2018. Aust Prescr. 2018;41(4):102–4.PubMedPubMedCentralCrossRefGoogle Scholar

The HIV-Infected Traveller

  1. Aung AK, Trubiano JA, Spelman DW. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): a review. Travel Med Infect Dis. 2015a;13(1):31–47.PubMedCrossRefGoogle Scholar
  2. Chadwick DR, Geretti AM. Immunization of the HIV infected traveler. AIDS. 2007;21:787–94.PubMedCrossRefGoogle Scholar
  3. Crum-Cianflone NF, Sullivan E. Vaccinations for the HIV-infected adult: a review of the current recommendations, part I. Infect Dis Ther. 2017a;6(3):303–31.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Crum-Cianflone NF, Sullivan E. Vaccinations for the HIV-infected adult: a review of the current recommendations, part II. Infect Dis Ther. 2017b;6(3):333–61.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Crum-Cianflone NF, Wallace MR. Vaccination in HIV-infected adults. AIDS Patient Care STDs. 2014;28(8):397–410.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Immunization of People Living with HIV and People and people at risk of HIV infection. Clinical protocol for the WHO European region. 2017.
  7. Ruff T, O’Brien DP. Advice to the HIV-infected traveller. In: Crowe S, Hoy J, Mills J, editors. Management of the HIV-infected patient. London: Martin Dunitz Ltd; 2002. p. 601–8.Google Scholar
  8. Sidibe M, Yactayo S, Kalle A, Sall AA, Sow S, Ndoutabe M, et al. Immunogenicity and safety of yellow fever vaccine among 115 HIV-infected patients after a preventive immunisation campaign in Mali. Trans R Soc Trop Med Hyg. 2012;106(7):437–44.PubMedCrossRefGoogle Scholar
  9. Veit O, Niedrig M, Chapuis-Taillard C, Cavassini M, Mossdorf E, Schmid P, et al. Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clin Infect Dis. 2009;48(5):659–66.PubMedCrossRefGoogle Scholar

The Immunocompromised Traveller

  1. Aung AK, Trubiano JA, Spelman DW. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): a review. Travel Med Infect Dis. 2015b;13(1):31–47.PubMedCrossRefGoogle Scholar
  2. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook, Australian Government Department of Health, Canberra; 2018. Accessed 1 Oct 2018. Section on “Vaccination of people who are immunocompromised.”
  3. Bialy C, Horne K, Dendle C, et al. International travel in the immunocompromised patient: a cross-sectional survey of travel advice in 254 consecutive patients. Intern Med J. 2015;45:618–23.PubMedCrossRefGoogle Scholar
  4. Centers for Disease Control and Prevention. CDC Yellow Book 2018: Health Information for International Travel. Chapter 8: Advising travelers with specific needs—immunocompromised travelers. New York: Oxford University Press; 2017. Accessed 24 July 2018.
  5. Hall V, Johnson D, Torresi J. Travel and biologic therapy: travel-related infection risk, vaccine response and recommendations. J Travel Med. 2018;25(1).Google Scholar
  6. Kotton C, Ryan E, Fishman J. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant. 2005;5:8–14.PubMedCrossRefGoogle Scholar
  7. Lortholary O, Charlier C, Lebeaux D, Lecuit M, Consigny PH. Fungal infections in immunocompromised travelers. Clin Infect Dis. 2013;56(6):861–9.PubMedCrossRefGoogle Scholar
  8. Rosdahl A, Herzog C, Frosner G, Noren T, Rombo L, Askling HH. An extra priming dose of hepatitis A vaccine to adult patients with rheumatoid arthritis and drug induced immunosuppression—a prospective, open-label, multi-center study. Travel Med Infect Dis. 2018;21:43–50.PubMedCrossRefGoogle Scholar
  9. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–18.PubMedCrossRefGoogle Scholar
  10. Schwartz BS, Rosen J, Han PV, et al. Immunocompromised travelers: demographic characteristics, travel destinations, and Pretravel Health Care from the U.S. Global TravEpiNet Consortium. Am J Trop Med Hyg. 2015;93:1110–6.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Suh K, Mileno MD. Challenging scenarios in a travel clinic: advising the complex traveler. Infect Dis Clin North Am. 2005;19:15–47.PubMedCrossRefGoogle Scholar
  12. Trofe-Clark J. Lemonovich TL and the AST Infectious Diseases Community of Practice. Interactions between anti-infective agents and immunosuppressants in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):318–26.PubMedCrossRefGoogle Scholar
  13. Trubiano JA, Johnson D, Sohail A, Torresi J. Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients. J Travel Med. 2016;23(6).PubMedCrossRefGoogle Scholar

The Splenectomised Traveller

  1. Boeddha C, de Graaf W, Overbosch D, van Genderen PJJ. Travel health preparation and travel-related morbidity of splenectomised individuals. Travel Med Infect Dis. 2012;10(4):197–200.PubMedCrossRefGoogle Scholar
  2. Crawford N, McMinn A, Nourse C, Philips L, Graham N, Jones P. Medical guidelines for individuals with asplenia or hyposplenism—paediatric guidelines (aged 0 to 18 years). Version 1, February 2016. Accessed 30 July 2018.
  3. Del Portillo HA, Ferrer M, Bruggat T, et al. The role of the spleen in malaria. Cell Microbiol. 2012;14(3):343–55.PubMedCrossRefGoogle Scholar
  4. Kuchar E, Miskiewicz K, Karlikowska M. A review of guidance on immunization in persons with defective or deficient splenic function. Br J Haematol. 2015;171(5):683–94.PubMedCrossRefGoogle Scholar
  5. McCarthy AE, Mileno M. Prevention and treatment of travel-related infections in compromised hosts. Curr Opin Infect Dis. 2006;19:450–5.PubMedCrossRefGoogle Scholar
  6. Rubin LG, Schaffner W. Clinical practice. Care of the asplenic patient. N Engl J Med. 2014;371(4):349–56.PubMedCrossRefGoogle Scholar
  7. Spelman D, Buttery J, Daley A, Isaacs D, et al. Guidelines for the prevention of sepsis in asplenic and hyposplenic patients. Intern Med J. 2008;38(5):349–56.PubMedCrossRefGoogle Scholar
  8. Spleen Australia Recommendations for the prevention of infection in asplenic or hyposplenic patients over 18 years of age. Version 33, August 2017. Accessed 30 July 2018.
  9. Vannier E, Krause PJ. Human babesiosis. N Engl J Med. 2012;366(25):2397–407.PubMedCrossRefGoogle Scholar
  10. Watson DA. Pretravel health advice for asplenic individuals. J Travel Med. 2003;10(2):117–21.PubMedGoogle Scholar

Medical Tourism

  1. Chen LH, Wilson ME. The globalization of healthcare: implications of medical tourism for the infectious disease clinician. Clin Infect Dis. 2013;57:1752–9.PubMedCrossRefGoogle Scholar
  2. Greenfield D, Pawsey M. Medical tourism raises questions that highlight the need for care and caution. Med J Aust. 2014;201:568–9.PubMedCrossRefGoogle Scholar
  3. Leggat P. Medical tourism. Aust Fam Physician. 2015;44(1–2):16–21.PubMedGoogle Scholar
  4. Nelson R. Infectious risks of medical tourism. Lancet Infect Dis. 2014;14(8):680–1.PubMedCrossRefGoogle Scholar
  5. Royal Australasian College of Surgeons. Position Paper on Medical Tourism, July 2017.

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Joseph Torresi
    • 1
    • 2
    • 3
    • 4
  • Sarah McGuinness
    • 5
    • 6
  • Karin Leder
    • 7
    • 8
  • Daniel O’Brien
    • 9
    • 10
  • Tilman Ruff
    • 11
    • 12
  • Mike Starr
    • 13
  • Katherine Gibney
    • 14
  1. 1.Professor of Medicine, Infectious Diseases Physician University of Melbourne, Department of Microbiology and ImmunologyThe Peter Doherty Institute for Infection and Immunity, The University of MelbourneMelbourneAustralia
  2. 2.Knox Private HospitalMelbourneAustralia
  3. 3.Epworth Eastern HospitalMelbourneAustralia
  4. 4.Austin HospitalMelbourneAustralia
  5. 5.Infectious Diseases Physician, Department of Infectious DiseasesThe Alfred Hospital and Monash UniversityMelbourneAustralia
  6. 6.Lecturer, Infectious Disease Epidemiology UnitSchool of Public Health and Preventive Medicine, Monash UniversityMelbourneAustralia
  7. 7.Professor of Medicine, Infectious Diseases Physician, Head of Infectious Disease EpidemiologySchool of Public Health and Preventive Medicine, Monash UniversityMelbourneAustralia
  8. 8.Head of Travel Medicine and Immigrant Health, Victorian Infectious Disease ServiceRoyal Melbourne Hospital Peter Doherty, Institute for Infection and ImmunityMelbourneAustralia
  9. 9.Associate Professor, Victorian Infectious Diseases ServiceRoyal Melbourne HospitalMelbourneAustralia
  10. 10.Department of Infectious DiseasesUniversity Hospital GeelongGeelongAustralia
  11. 11.Associate Professor, Nossal Institute for Global HealthSchool of Population and Global Health, The University of MelbourneMelbourneAustralia
  12. 12.International Medical Advisor, Australian Red Cross (1996–2019)Founding Head of Travel Medicine at Fairfield and Royal Melbourne HospitalsMelbourneAustralia
  13. 13.Paediatrician, Infectious Diseases Physician, Consultant in Emergency Medicine, Director of Paediatric Education, Royal Children’s Hospital Melbourne, Honorary Clinical Associate Professor, University of MelbourneMelbourneAustralia
  14. 14.Infectious Diseases Physician, Public Health Physician and Senior Research FellowThe Austin Hospital, The Royal Melbourne Hospital, and The University of Melbourne, at The Peter Doherty Institute for Infection and ImmunityMelbourneAustralia

Personalised recommendations